Basically, bioprinting and AI should be able to do real-time organoids tests and assemble high-quality in vitro models. Professor Hyungseok Lee, from the Department of Mechanical and Biomedical Engineering at Kangwon National University, presented his views on the future development of organoid manufacturing on May 6 in Cyborg and Bionic Systems. Organoids that can auto-organize and make up can be great for research and applications.
Bioprinting could help automate manufacturing processes. High resolution is the criteria for bioprinting organoids. Bioprinting is a process in organoid manufacturing to have different kinds of 3D shapes and structures. Organoids could also be used as standby for clinical patients to help them decide on the best therapeutic agents. The organoid can not exhibit the same properties for screening because of differences in experimenter, culture, and cell conditions.